Banka Bioloo Limited has secured listing and trading approval for 9,500 equity shares allotted under its Employee Stock Option Plan (ESOP). The National Stock Exchange of India Limited (NSE) granted the approval on June 25, 2026, with the effective date for dealings set as June 29, 2026. This development increases the number of equity shares available for trading under the BANKA symbol on the exchange.

The allotment consists of equity shares of Rs. 10 each, which have been admitted to dealings on the NSE. The distinctive numbers for these securities range from 10922433 to 10931932. The company submitted the application for this listing of further issue pursuant to the ESOP allotment made by the company.

The following table details the securities listed:

The company is required to provide all critical and price-sensitive information through the NSE Electronic Application Processing System (NEAPS). This online filing facility ensures quicker and efficient processing of submissions under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Manjula Chunduru, Company Secretary & Compliance Officer of Banka Bioloo Limited, confirmed the receipt of the approval letter from the exchange. The listing department of the NSE has recorded the reference number NSE/LIST/2026/55966 for this transaction.

Banka BioLoo Limited returned to profitability in FY26, reporting a net profit of ₹38.21 lakh compared to a loss of ₹929.64 lakh in the previous year. The company achieved this turnaround through an 8.6% increase in revenue to ₹6,101.18 lakh and a significant improvement in operational efficiency. The strong performance was led by a robust Q4, where revenue grew 28% year-on-year to ₹1,802.28 lakh, and net profit reached ₹157.06 lakh.

The company’s EBITDA swung to a positive ₹407.9 lakh for the full year, a marked recovery from a loss of ₹487.9 lakh in FY25. This improvement was driven by cost optimization and higher execution in the Water, Sanitation & Hygiene (WaSH) segment. Earnings per share (EPS) recovered to ₹0.35 for the year, compared to a loss of ₹8.57 per share in the prior year.

Financial Performance

The standalone financial results for Q4 and FY26 highlight a decisive recovery in the company's bottom line. The following table details the key financial metrics:

Order Book and Business Segments

Banka BioLoo’s total unexecuted order book stands at ₹107 crore, with a 12-month order book of ₹82 crore. The WaSH segment contributed significantly, securing new orders worth approximately ₹16 crore in Q4 FY26, bringing the 12-month total WaSH order booking to ₹56 crore. The company expanded its footprint into Bangalore and Mumbai with projects from Brigade, Reliance, and RMZ.

The Railways segment did not receive new orders in Q4 FY26, but the total unexecuted orders for the business stand at approximately ₹38 crore year-to-date. The 12-month Railways order booking was approximately ₹26 crore. The company maintains a presence across 7 Indian Railways zones and 26 states, with over 25,000 bio toilets installed and 25,000 systems under daily operation and maintenance.

Consolidated Results

On a consolidated basis, the company reported a net profit of ₹39.31 lakh for FY26, recovering from a loss of ₹890.87 lakh in the previous year. Total income for the year stood at ₹5,838.61 lakh, an increase of 7.1% year-on-year. Consolidated EBITDA turned positive at ₹622.49 lakh, compared to a loss of ₹283.19 lakh in FY25, reflecting the company’s improved operational leverage across its business verticals.